Cellectis (CLLS) Gross Profit Growth (1y) (2016 - 2023)
Cellectis (CLLS) Gross Profit Growth (1y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 41.37% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 16.94% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 68.41% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cellectis | 285.50 Mn | 99.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,392.86% |
| Sep 30, 2023 | -10.42% |
| Jun 30, 2023 | -87.42% |
| Mar 31, 2023 | -709.38% |
| Dec 31, 2022 | 168.85% |
| Sep 30, 2022 | 78.69% |
| Jun 30, 2022 | 269.20% |
| Mar 31, 2022 | 101.37% |
| Dec 31, 2021 | 98.78% |
| Sep 30, 2021 | 45.09% |
| Jun 30, 2021 | 80.25% |
| Mar 31, 2021 | -105.15% |
| Dec 31, 2020 | -306.43% |
| Sep 30, 2020 | -138.79% |
| Jun 30, 2020 | -968.55% |
| Mar 31, 2020 | 10,017.33% |
| Dec 31, 2019 | -595.56% |
| Sep 30, 2019 | 11,034.21% |
| Jun 30, 2019 | -95.67% |
| Mar 31, 2019 | -91.76% |